Skip to main content
. 2015 Jun 20;25(Suppl 1):15–21. doi: 10.1159/000433437

Fig. 1.

Fig. 1

A model for peptide ligand binding to incretin receptors. The helical region of the peptide ligand binds to the NTD of the receptor, allowing the N-terminal region of the peptide to interact with the receptor's TMD.